vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Regional Management Corp. (RM). Click either name above to swap in a different company.

Regional Management Corp. is the larger business by last-quarter revenue ($167.3M vs $104.5M, roughly 1.6× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 9.4%). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 8.2%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Millennium Management LLC is an investment management firm with a multistrategy hedge fund offering. It is one of the world's largest alternative asset management firms with $83.4 billion assets under management as of January 2026. The firm operates in America, Europe and Asia. As of 2022, Millennium had posted the fourth highest net gains of any hedge fund since its inception in 1989.

IMCR vs RM — Head-to-Head

Bigger by revenue
RM
RM
1.6× larger
RM
$167.3M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+14.9% gap
IMCR
24.3%
9.4%
RM
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
8.2%
RM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IMCR
IMCR
RM
RM
Revenue
$104.5M
$167.3M
Net Profit
$11.4M
Gross Margin
97.4%
Operating Margin
-18.8%
Net Margin
6.8%
Revenue YoY
24.3%
9.4%
Net Profit YoY
62.7%
EPS (diluted)
$-0.61
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
RM
RM
Q1 26
$167.3M
Q4 25
$104.5M
$169.7M
Q3 25
$103.7M
$165.5M
Q2 25
$98.0M
$157.4M
Q1 25
$93.9M
$153.0M
Q4 24
$84.1M
$154.8M
Q3 24
$80.2M
$146.3M
Q2 24
$75.4M
$143.0M
Net Profit
IMCR
IMCR
RM
RM
Q1 26
$11.4M
Q4 25
$12.9M
Q3 25
$-177.0K
$14.4M
Q2 25
$-10.3M
$10.1M
Q1 25
$5.0M
$7.0M
Q4 24
$9.9M
Q3 24
$8.7M
$7.7M
Q2 24
$-11.6M
$8.4M
Gross Margin
IMCR
IMCR
RM
RM
Q1 26
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Operating Margin
IMCR
IMCR
RM
RM
Q1 26
Q4 25
-18.8%
9.5%
Q3 25
-6.9%
11.5%
Q2 25
-15.2%
8.6%
Q1 25
-3.9%
6.0%
Q4 24
-23.1%
8.2%
Q3 24
-10.6%
6.9%
Q2 24
-21.2%
7.8%
Net Margin
IMCR
IMCR
RM
RM
Q1 26
6.8%
Q4 25
7.6%
Q3 25
-0.2%
8.7%
Q2 25
-10.5%
6.4%
Q1 25
5.4%
4.6%
Q4 24
6.4%
Q3 24
10.9%
5.2%
Q2 24
-15.4%
5.9%
EPS (diluted)
IMCR
IMCR
RM
RM
Q1 26
$1.18
Q4 25
$-0.61
$1.30
Q3 25
$0.00
$1.42
Q2 25
$-0.20
$1.03
Q1 25
$0.10
$0.70
Q4 24
$-0.47
$0.96
Q3 24
$0.17
$0.76
Q2 24
$-0.23
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
RM
RM
Cash + ST InvestmentsLiquidity on hand
$864.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$375.8M
Total Assets
$1.1B
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
RM
RM
Q1 26
Q4 25
$864.2M
Q3 25
$892.4M
Q2 25
$882.8M
Q1 25
$837.0M
Q4 24
$820.4M
Q3 24
$901.3M
Q2 24
$859.6M
Total Debt
IMCR
IMCR
RM
RM
Q1 26
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$438.7M
$1.4B
Q2 24
$452.5M
$1.4B
Stockholders' Equity
IMCR
IMCR
RM
RM
Q1 26
$375.8M
Q4 25
$381.0M
$373.1M
Q3 25
$396.6M
$371.9M
Q2 25
$388.5M
$363.0M
Q1 25
$378.5M
$357.9M
Q4 24
$360.7M
$357.1M
Q3 24
$377.8M
$352.9M
Q2 24
$359.1M
$344.9M
Total Assets
IMCR
IMCR
RM
RM
Q1 26
$2.1B
Q4 25
$1.1B
$2.1B
Q3 25
$1.1B
$2.0B
Q2 25
$1.1B
$2.0B
Q1 25
$1.0B
$1.9B
Q4 24
$1.0B
$1.9B
Q3 24
$1.1B
$1.8B
Q2 24
$1.0B
$1.8B
Debt / Equity
IMCR
IMCR
RM
RM
Q1 26
Q4 25
4.40×
Q3 25
4.23×
Q2 25
4.14×
Q1 25
4.11×
Q4 24
4.12×
Q3 24
1.16×
3.94×
Q2 24
1.26×
3.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
RM
RM
Operating Cash FlowLast quarter
$-32.7M
Free Cash FlowOCF − Capex
$-35.5M
FCF MarginFCF / Revenue
-34.0%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
RM
RM
Q1 26
Q4 25
$-32.7M
$309.1M
Q3 25
$-4.5M
$86.7M
Q2 25
$26.0M
$78.7M
Q1 25
$435.0K
$63.7M
Q4 24
$-14.0M
$268.9M
Q3 24
$21.1M
$75.1M
Q2 24
$23.5M
$71.5M
Free Cash Flow
IMCR
IMCR
RM
RM
Q1 26
Q4 25
$-35.5M
$304.3M
Q3 25
$-5.2M
$85.7M
Q2 25
$25.6M
$77.6M
Q1 25
$137.0K
$62.4M
Q4 24
$-17.5M
$263.9M
Q3 24
$20.3M
$73.8M
Q2 24
$23.1M
$70.3M
FCF Margin
IMCR
IMCR
RM
RM
Q1 26
Q4 25
-34.0%
179.3%
Q3 25
-5.0%
51.8%
Q2 25
26.1%
49.3%
Q1 25
0.1%
40.8%
Q4 24
-20.9%
170.4%
Q3 24
25.3%
50.4%
Q2 24
30.7%
49.1%
Capex Intensity
IMCR
IMCR
RM
RM
Q1 26
Q4 25
2.8%
2.8%
Q3 25
0.7%
0.6%
Q2 25
0.4%
0.6%
Q1 25
0.3%
0.8%
Q4 24
4.3%
3.3%
Q3 24
1.0%
0.9%
Q2 24
0.4%
0.8%
Cash Conversion
IMCR
IMCR
RM
RM
Q1 26
Q4 25
23.94×
Q3 25
6.04×
Q2 25
7.76×
Q1 25
0.09×
9.09×
Q4 24
27.13×
Q3 24
2.42×
9.80×
Q2 24
8.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons